Improving cell and gene therapy safety and performance using next-generation Nanoplasmid vectors
{{output}}
The cell and gene therapy industry has employed the same plasmid technology for decades in vaccination, cell and gene therapy, and as a raw material in viral vector and RNA production. While canonical plasmids contain antibiotic resistance markers in bacterial... ...
